Hospira Dacarbazine for Injection 600 mg/ vial

Land: Australië

Taal: Engels

Bron: Department of Health (Therapeutic Goods Administration)

Werkstoffen:

dacarbazine, Quantity: 600 mg

Beschikbaar vanaf:

Hospira Australia Pty Ltd

INN (Algemene Internationale Benaming):

Dacarbazine

farmaceutische vorm:

Injection, powder for

Samenstelling:

Excipient Ingredients: citric acid monohydrate; mannitol; sodium hydroxide

Toedieningsweg:

Intravenous

Eenheden in pakket:

1 x 100 mL vial

klasse:

Medicine Listed (Export Only)

Prescription-type:

Not scheduled. Not considered by committee

therapeutische indicaties:

Dacarbazine is indicated for the treatment of patients with metastatic malignant melanoma. Dacarbazine is used as part of combination chemotherapy for the treatment of advanced Hodgkin's disease, advanced adult soft tissue sarcomas (except mesothelioma and Kaposi sarcoma). Dacarbazine has been shown, when used in combination with other cytotoxic agents, to be of use in the treatment of other malignant diseases including carcinoma of the colon, ovary, breast, lung, testicular teratoma, and solid tumours in children.

Product samenvatting:

Visual Identification: A white or very pale yellow powder or plug; Container Type: Vial; Container Life Time: 18 Months

Autorisatie-status:

Listed (Export Only)

Autorisatie datum:

2006-03-10